Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-02-14
2006-02-14
Mosher, Mary E. (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S235100, C435S091400, C435S091410, C435S069300
Reexamination Certificate
active
06998252
ABSTRACT:
Recombinant poxviruses, such as vaccinia, are provided that comprises a segment comprised of (A) a first DNA sequence encoding a polypeptide that is foreign to poxvirus and (B) a poxvirus transcriptional regulatory sequence, wherein (i) said transcriptional regulatory sequence is adjacent to and exerts transcriptional control over said first DNA sequence and (ii) said segment is positioned within a nonessential genomic region of said recombinant poxvirus. Vaccines, carriers, cells, and media comprising recombinant poxviruses, and methods of immunization with recombinant poxviruses also are provided.
REFERENCES:
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4722848 (1988-02-01), Paoletti et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 5110587 (1992-05-01), Paoletti et al.
patent: 5155020 (1992-10-01), Paoletti
patent: 5174993 (1992-12-01), Paoletti
patent: 5204243 (1993-04-01), Paoletti
patent: 5225336 (1993-07-01), Paoletti
patent: 5266313 (1993-11-01), Esposito et al.
patent: 5338683 (1994-08-01), Paoletti
patent: 5364773 (1994-11-01), Paoletti et al.
patent: 5494807 (1996-02-01), Paoletti et al.
patent: 5505941 (1996-04-01), Paoletti
patent: 5583028 (1996-12-01), Paoletti et al.
patent: 0083286 (1983-07-01), None
patent: 0284416 (1988-09-01), None
patent: 0338807 (1989-10-01), None
patent: 0397560 (1990-11-01), None
patent: 0397560 (1990-11-01), None
patent: WO-89/03429 (1989-04-01), None
patent: WO 89/03429 (1989-04-01), None
patent: WO 89/12684 (1989-12-01), None
patent: WO89/12684 (1989-12-01), None
patent: WO-93/25666 (1993-12-01), None
patent: WO 93/25666 (1993-12-01), None
Boyle and Coupar, J. Gen. Virol. 67: 1591-1600.
Boyle et al, Virology 156: 355-365.
Muller et al, J. Gen. Virol. 38:135-147.
Prideaux et al, Arch. Virol. 96:185-199.
Schnitzlein et al, Virus Research 10:65-75.
Arif, Advances in Virus Research 29:195-213.
Langridge, Journal of Invertebrate Pathology 42: 369-375.
Massung et al. Virology 180:355-364.
Foley et al, Annals of the New York Academy of Science, 646:220-222.
Joklik et al, 17th edition Zinser Microbiology, 1Apple-Centurion-Crofts, New York, p. 1009.
Pickup DJ et al. Proceedings of the National Academy of Sciences USA 79: 7112-6.
McFadden et al (Cell 18:101-8, Sep. 1979).
Moss et al (Journal of Virology 40:387-95, Nov. 1981).
Nakano et al (PNAS 79: 1593-1596, Mar. 1, 1982.
Panicali et al (PNAS 79:4927-4931, Aug. 1982).
Weir et al (PNAS 79(4): 1210-1214, Feb. 15, 1982).
Moyer et al (Virology 102:119-132, 1980).
Mackett et al (PNAS 79:7415-7419, Dec. 1, 1982).
Esposito et al (Virology 165:313-6, Jul. 1988).
Boyle et al (Virus Research 10:343-356, 1988).
Taylor et al (Vaccine 6:497-503, Dec. 1988).
Taylor et al (Vaccine 6:504-508, Dec. 1988).
Venkatesan et al (Cell 125:805-814, 1981).
Weir et al (Journal of Virology 46(2): 530-7, May 1983).
Weir et al (Journal of virology 51(3):662-669, 1984).
Bertholet et al (PNAS 82(7): 2096-2100, Apr. 1985).
Boyle et al (Journal of General Virology 67:1591-1600, 1986).
Panicali et al (PNAS 80(17): 5364-5368, Sep. 1, 1983).
Smith et al, Nature 302 (5908): 490-5,Apr. 7, 1983.
Smith et al, PNAS 80:23, 7155-7159, Dec. 1, 1983.
Webster's New World Dictionary of the American Language. College Edition. 1968. The World Publishing Company, Cleveland and New York. p. 18.
Baldick et al.,J. Virol.66: 4710-4719 (1992).
Belle et al.,Virology112: 306-317 (1981).
Bertholet et al.,Proc. Nat'l. Acad. Sci. USA82: 2096-2100 (1985).
Boone et al.,Virology79: 67-80 (1977).
Fenner et al.,Virology11: 185 (1960).
Green et al.,Cell22: 231-242 (1980).
Hanafusa et al.,Biken J.2: 85-91 (1959).
Hruby et al.,J. Virol29: 705-715 (1979).
Hruby et al.,Proc. Nat'l. Acad. Sci. USA76: 1887-1890 (1979).
Lee-Chen et al.,Virology163: 64-79 (1988).
Lee-Chen et al.,Virology163: 80-92 (1988).
Maxam et al.,Proc. Nat'l. Acad. Sci. USA74: 560-564 (1977).
Moss,Comprehensive Virology,Fraenkel-Conrat, H. and Wagner, R.R., pp. 405-474 (1974).
Munyon et al.,J. Virol5: 32- (1970).
Obert et al.,Biochem. Biophys. Res. Commun.44: 362- (1971).
Panicali et al.,J. Virol.37: 1000-1010 (1981).
Pennington et al.,J. Virol.13: 488-493 (1974).
Rosel et al.,J. Virol.56: 830-838 (1985).
Rosel et al.,J. Virol.60: 436-449 (1986).
Venkatesan et al.,Cell125: 805-813 (1981).
Venkatesan et al.,J. Virol.44: 637-646 (1982).
Weaver et al.,Nucl. Acids Res.7: 1175-1193 (1979).
Weir et al.,J. Virol.51: 662-669 (1984).
Cooper et al.,J. Virol.37: 284-294 (1981).
Cooper et al.,J. Virol.39: 733-745 (1981).
Venkatesan,J. Virol.37: 738-747 (1981).
Kent, “Isolation and Analysis of the Vaccinia Virus P4B Gene Promoter”,Ph.D. Dissertation, University of Cambridge(1988).
Paolett et al.,J. Virol.33:208-219 (1980).
Wittek et al.,Cell21:481-493 (1980).
Paoletti et al.,Proc. Natl. Acad. Sci. USA81: 194-196 (1984).
Cheng et al.,J. Virol.60: 337-344 (1986).
Coupar et al.,Eur. J. Immunol.16: 1479-1487 (1986).
Coupar et al.,J. gen. Virol.68: 2299-2309 (1987).
McCarthy et al.,Virology59: 59-69 (1974).
Munyon et al.,J. Virology,pp. 813-820 (Jun. 1971).
Munyon et al.,Federation Proceedings31(6) (Nov.-Dec. 1972).
Sam & Dumbell,Ann. Virol.{Inst. Pasteur}. 132E, pp. 135-150 (1981).
Weir et al.,Proc. Natl. Acad. Sci. USA79:1210-1214 (1982).
Panicali et al.,Proc. Natl. Acad. Sci. USA79: 4927-4931 (1982).
Panicali et al.,Proc. Natl. Acad. Sci. USA80: 5364-5368 (1983).
Panicali et al.,Proc. Natl. Acad. Sci. USA81: 193-197 (1984).
Moss,Virology,pp. 2079-2111, Raven Press (1990).
Hanafusa et al.,Bikens' J.2:77-82 (1959).
Fenner et al.,Virology11:185-201 (1960).
Boyle et al.,J. gen. Virol.67: 1591-1600 (1986).
Boyle et al.,Virus Res.10: 343-356 (1988).
Taylor et al.,Vaccine6: 497-503 (1988).
Spehner et al.,J. Virol.64: 527-533 (1990).
Post et al.,Cell25:227-232 (1981).
Peabody et al.,Molec.&Cell Biol.6:2704-2711 (1986).
Perez et al.,J. Virol.,61: 1276-81 (1987).
Geballe et al.,J. Virol.62: 3334-3340 (1988).
Hensel et al.,J. Virol.63: 4986-4990 (1989).
Davison et al.,J. Mol. Biol.210: 749-769 (1989).
Decision of Opposition Div. regarding Eur. Pat. No. 0110385, including annexes (Oct. 25, 1996).
Pox-Iridovirus Meeting, Participant Housing List (Sep. 20-23, 1982) and Abstracts 1-61.
Moyer et al.,Virol.102: 119-32 (1980).
Dumbell et al.,Nature286: 29-32 (1980).
Archard et al.,J. Gen. Virol.45: 51-63 (1979).
Weir et al.,Proc. Nat'l Acad. Sci. USA79: 1210-14 (1982).
Moss et al.,J. Virol.40: 387-95 (1981).
Eposito et al.,Virol.165: 313-316 (1988).
Boyle et al.,Vir. Res.10: 343-56 (1988).
Drillen et al.,Virol.160 (203-09 (1987).
Sphener et al.,J. Virol.64: 527-33 (1990).
Binns et al.,Isr. J. Vet. Med.42: 124-27 (1986).
Fleming et al.,Virol.187: 464-71 (1992).
Boursnell et al.,J. Gen. Virol.71: 621-28 (1990).
Boursnell et al.,Virol.178: 297-300 (1990).
van der Leek et al.,Vet. Rec.134: 13-18.
Patel et al.,Proc. Nat'l Acad. Sci. USA85: 9431-35 (1988).
Kumar et al.,Arch. Virol.112: 139-48.
Pearson et al.,Virol.180: 561-66 (1991).
Sam et al.,Ann. Virol.132: 135-50 (1981).
L.C. Archard et al., “Restriction Endonuclease Analysis of Red Cowpox Virus and its White Pock Variant”, J. gen. Virol., 1979, pp. 51-63, vol. 45.
Basil M. Arif, “The Entomopoxviruses”, Advances in Virus Research, pp. 195-213, vol. 29.
Noel Barrett et al., “Large-Scale Production and Purification of a Vaccinia Recombinant-Derived HIV-1 gp160 and Analysis of Is Immunogenicity”, AIDS Research and Human Retroviruses, 1989, pp. 159-171, vol. 5, No. 2.
Christine Bertholet et al., “One Hundred Base Paris of 5$Λ{\prime}$ Flanking Sequence of a Vaccinia Virus Late Gene are Sufficient to Temporally Regulate Late Transcription”, Proceedings of the National Academy of Sciences of the United States of America, 1985, pp. 2096-2100, vol. 82, No. 7.
M.M. Binns, et al., “Prospects for a Novel Genetically Engineered Vaccine Against Infectious Bronchitis”, Isr. J. Vet. Med., 1986, pp. 124-127, vol. 42, No. 2.
Michael Boshart et al., “A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus”, Cell, 1985, pp. 521
Mackett Michael
Moss Bernard
Smith Geoffrey L.
Heller Ehrman LLP
Mosher Mary E.
The United States of America as represented by the Department of
LandOfFree
Recombinant poxviruses having foreign DNA expressed under... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant poxviruses having foreign DNA expressed under..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant poxviruses having foreign DNA expressed under... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3687626